Technology Committee Event: Accelerating Innovation in the Start-up Nation
Technology Committee Event
Accelerating Innovation in the Start-up Nation
Elka Nir, CEO, Carmel Ltd & Carmel Innovation Funds
08:00 – 10:00, Monday, 9 December 2019
Venue: 1F, Residence Three, Grand Hyatt Taipei, /台北君悅大飯店 君寓三 (1F)
Address: 2 Song Shou Road, Xin Yi District, Taipei / 台北市信義區松壽路2號
Israel is often referred to as the “start-up nation” and shares many similarities with Taiwan. For example, both have prospered economically despite difficult political circumstances, both have made remarkable global impacts that are disproportionate to their size and population, and both have pursued cutting-edge technologies. Israel is known for its innovation, R&D expertise and quality products in terms of IT, software, biotech, medical devices FinTech, cybersecurity and autonomous vehicles, among others and Taiwan is known for precision manufacturing of the latest technological devices. As Taiwan is shifting its dependency from manufacturing to added value solutions and services technologies such as IoT and AI-related products, it opens the possibility for potential synergistic future relationships with Israeli corporations. Our guest speaker will draw on her extensive experience to outline how to turn innovative ideas into viable business successes.
Among other subjects in her presentation, our speaker will cover the following:
- The Innovation arena in Israel
- Innovation at Haifa university
- Economic cooperation between academia and business and innovative ways to accelerate innovation in the market
- Various technologies and examples of start-up companies.
About the speaker
Elka Nir is currently the CEO of Carmel, the economic corporation of Haifa University and CEO of the Carmel Innovation Fund, which she founded and has managed for several years. She has more than 25 years of experience in the areas of high tech and life sciences and has held a number of senior executive and board leadership roles in large global companies as well as roles in fundraising and strategic alliances. She has in-depth knowledge of the Israeli hi-tech market including the strong network of start-ups at various stages, incubators, local and global investors, technology and innovation centers as well as strategic players. She is an active chairperson and board member of several public and private life sciences companies in various stages, in Israel and globally. She also works closely with Israeli funds. Among others, Elka is a lead independent director of the board of directors of the Trendlines group (listed in Singapore) which leads several technological incubators. She is also a board director of the Israeli High Tech Association (IATI). Prior to her current positions, she was the Managing Director of Life Sciences in Giza Venture Capital, leading investment and business successes in its portfolio of companies. Previously she was the COO & Director of Development and Operations at Biosense Webster (Israel), Johnson & Johnson as well as VP of R&D and VP of marketing at General Electric Medical Systems (GE) in Israel.
This event will be conducted in English.